Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/1998
08/27/1998WO1998037094A2 Secreted proteins and polynucleotides encoding them
08/27/1998WO1998037082A1 7a-HETEROCYCLE-SUBSTITUTED HEXAHYDRO-1H-PYRROLIZINE COMPOUNDS USEFUL IN CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION
08/27/1998WO1998037079A1 N-heterocyclic derivatives as nos inhibitors
08/27/1998WO1998037077A1 Calcitonin mimetics
08/27/1998WO1998037072A1 Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase
08/27/1998WO1998037071A1 Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds
08/27/1998WO1998036771A1 Method for the production of vaccines against cell surface proteins
08/27/1998WO1998036764A2 Method of treating psychological and metabolic disorders using igf or igf/igfbp-3
08/27/1998WO1998036761A1 Anti-proliferative preparations
08/27/1998WO1998036748A1 Methods and compositions for the protection of mitochondria
08/27/1998WO1998036746A1 Use of substituted (5,6)-dihydronaphthalenyl compounds having retinoid-like activity to prevent or reduce ischemic injury
08/27/1998WO1998036745A2 Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis
08/27/1998WO1998036742A1 Methods and compositions for preventing and treating chronological aging in human skin
08/27/1998WO1998036733A2 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
08/27/1998WO1998027930A3 New use of aminopiperazine derivatives
08/27/1998WO1998017814A3 Gene expression and delivery systems and uses
08/27/1998DE19708454A1 Die Proliferation von Zellen inhibierendes Peptid und dessen Verwendung The proliferation of cells inhibiting peptide and use thereof
08/27/1998DE19707628A1 Oxazolidinone Oxazolidinones
08/27/1998CA2282859A1 Method for the production of vaccines against cell surface proteins
08/27/1998CA2282302A1 Morphogenic proteins
08/27/1998CA2281948A1 Inhibition of major groove dna binding proteins by modified polyamides
08/27/1998CA2281947A1 Improved polyamides for binding in the minor groove of double stranded dna
08/27/1998CA2281930A1 Design, synthesis and use of specific polyamide dna-binding ligands
08/27/1998CA2281893A1 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics
08/27/1998CA2281890A1 Method of treating psychological and metabolic disorders using igf or igf/igfbp-3
08/27/1998CA2281800A1 7a-heterocycle-substituted hexahydro-1h-pyrrolizine compounds useful in controlling chemical synaptic transmission
08/27/1998CA2281564A1 Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds
08/27/1998CA2281509A1 Use of substituted (5,6)-dihydronaphthalenyl compounds having retinoid-like activity to prevent or reduce ischemic injury
08/27/1998CA2281059A1 Secreted proteins and polynucleotides encoding them
08/26/1998EP0860506A1 Human protein kinase hYAKI (HOACF 72)
08/26/1998EP0860502A1 cDNA clone HDPBI30 that encodes a novel human 7-transmembrane receptor
08/26/1998EP0860445A1 New nucleotide sequences for the cell cycle regulated expression of structural genes
08/26/1998EP0860422A1 Derivatives of benzylidene cyclohexanone, benzylidene cyclopentanone, and benzylidene acetone and their synthesis.
08/26/1998EP0859853A1 Method for transferring genes to the heart using aav vectors
08/26/1998EP0859834A2 A paf-acetylhydrolase and use in therapy
08/26/1998EP0859787A1 G-protein coupled receptor hnfds78
08/26/1998EP0859784A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation
08/26/1998EP0859779A1 Interleukin converting enzyme and apoptosis
08/26/1998EP0859771A1 Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
08/26/1998EP0859769A1 Esters of non-steroidal anti-inflammatory carboxylic acids
08/26/1998EP0859763A1 Dihydrophthalazine antagonists of excitatory amino acid receptors
08/26/1998EP0859760A1 Tricyclic pyrrolidine derivatives as calcium channel antagonists
08/26/1998EP0859638A1 Method for inhibiting cell-mediated killing of target cells
08/26/1998EP0859607A1 Guanidino protease inhibitors
08/26/1998EP0741715B1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use
08/26/1998EP0739336B1 Gem-disubstituted azacyclic tachykinin antagonists
08/26/1998EP0558603B1 Retroviral protease inhibitors
08/26/1998EP0479948B1 Compositions and methods for the synthesis of natriuretic protein receptor b and methods of use
08/26/1998EP0423326B1 Novel physiologically active peptide and calcium metabolism-regulating agent comprising said peptide as effective ingredient
08/26/1998CN1191533A 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivs. as neurokinin receptor antagonists
08/26/1998CN1191530A Manganese or iron complexes of nitrogen-contg. macrocyclic ligands effective as catalysts for dismutating superoxide
08/26/1998CN1191491A 结缔组织生长因子 Connective tissue growth factor
08/26/1998CN1191487A Method for inhibiting vascular smooth muscle cell migration
08/26/1998CN1191485A Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substd. amino 1, 2, 3-triazoles
08/26/1998CN1191484A Melatonin agonists for treating benign prostatic hyperplasia
08/26/1998CA2225174A1 Rat cathepsin k polynucleotide & polypeptide sequence
08/25/1998US5798448 AL-1 neurotrophic factor antibodies
08/25/1998US5798373 Tri-substituted phenyl derivatives useful as PDE IV inhibitors
08/25/1998US5798363 Use for tachykinin antagonists to treat emesis
08/25/1998US5798362 Useful as alpha-adrenoreceptor blockers; condensation
08/25/1998US5798357 Thromboxane synthetase inhibitors
08/25/1998US5798355 Inhibitors of rotamase enzyme activity
08/25/1998US5798354 Cosmetic, therapy
08/25/1998US5798353 Treating eating disorder, obesity, diabetes, psychological disorder, sexual disorder, psychosis, memory disorder
08/25/1998US5798352 Antithrombotic amidinotetrahydropyridylalanine derivatives
08/25/1998US5798351 Useful for inhibiting bone loss, lowering seum cholesterol levels and treating hormone dependent mammalian breast and uterine cancer
08/25/1998US5798342 Use of natural cyclodextrins and their derivatives for the solubilization of platelet anti-aggregating agents from the family of ginkgolides
08/25/1998US5798248 Recombinant mutant thrombin receptor and related pharmaceuticals
08/25/1998US5798228 Recombinant production of dog and horse type I interferons
08/25/1998US5798225 Process for recombinant production of PTH and PTHrp analogs
08/25/1998US5798116 Stabilized materials comprised of copper ion-containing fibronectin mats
08/25/1998US5797906 Retrograde tissue splitter and method
08/25/1998CA2224111A1 Novel compounds
08/25/1998CA2160440C Method of manufacturing non-absorbable synthetic sulfated polysaccharides
08/25/1998CA2137677C Stabilized somatotropin for parenteral administration
08/25/1998CA2122479C Risedronate delayed-release compositions
08/25/1998CA2077420C Imidazoindolizine derivatives and process for preparation thereof
08/25/1998CA2006723C Sulfur-containing heterocyclic compounds
08/24/1998CA2220855A1 Cdna clone hdpb130 that encodes a novel human 7-transmembrane receptor
08/20/1998WO1998036075A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof
08/20/1998WO1998036069A1 Novel human mago nashi protein
08/20/1998WO1998036068A2 Human p24 vesicle proteins
08/20/1998WO1998036067A2 Secreted proteins and polynucleotides encoding them
08/20/1998WO1998036002A1 Cross-linked vinyl polymers with bile acid adsorbing effect
08/20/1998WO1998035986A1 Receptor that binds trail
08/20/1998WO1998035983A1 The proliferation of cell-inhibiting peptide and its use
08/20/1998WO1998035979A1 Oligomers which inhibit expression of collagen genes
08/20/1998WO1998035978A1 Aminooxy-modified oligonucleotides
08/20/1998WO1998035966A1 Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-yl)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders
08/20/1998WO1998035963A1 Process for preparing eprosartan
08/20/1998WO1998035962A1 Process for preparing eprosartan
08/20/1998WO1998035958A1 Phthalazines with angiogenesis inhibiting activity
08/20/1998WO1998035957A1 Amide derivatives as selective neuropeptide y receptor antagonists
08/20/1998WO1998035952A1 Oxiran carboxylic acids for the treatment of diabetes
08/20/1998WO1998035951A2 New aminopiperazine derivatives
08/20/1998WO1998035949A1 Bicyclic amino acids
08/20/1998WO1998035948A1 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists
08/20/1998WO1998035945A1 4-aminoalkoxy-1h-benzimidazole derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists
08/20/1998WO1998035943A1 4-aminoethoxyindazole derivatives
08/20/1998WO1998035942A1 4-aminoethoxyindazole derivatives
1 ... 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 ... 1564